Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Finished Goods (2016 - 2026)

Orthofix Medical has reported Finished Goods over the past 16 years, most recently at $87.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Finished Goods fell 4.21% year-over-year to $87.7 million, compared with a TTM value of $87.7 million through Mar 2026, down 4.21%, and an annual FY2025 reading of $86.2 million, down 18.18% over the prior year.
  • Finished Goods came in at $87.7 million for Q1 2026, up from $86.2 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $140.7 million in Q3 2023 to a low of $24.6 million in Q1 2022.
  • Median Finished Goods over the past 5 years was $91.6 million (2025), compared with a mean of $97.6 million.
  • The sharpest move saw Finished Goods surged 471.49% in 2023, then crashed 31.16% in 2025.
  • Over 5 years, Finished Goods stood at $63.9 million in 2022, then soared by 119.6% to $140.3 million in 2023, then dropped by 24.89% to $105.4 million in 2024, then dropped by 18.18% to $86.2 million in 2025, then rose by 1.79% to $87.7 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Finished Goods are $87.7 million (Q1 2026), $86.2 million (Q4 2025), and $88.3 million (Q3 2025).